XENE
Xenon Pharmaceuticals Inc
stockNASDAQ
xenon® (nasdaq: xene) is a biopharmaceutical company focused on the development of novel medicines through the application of our proprietary discovery platform, which we refer to as extreme genetics. our product candidates are based on genetic insights derived from our research of families where individuals exhibit severe traits, or phenotypes. we apply our expertise to predict which phenotypes are caused by single-gene defects. by identifying and characterizing the single-gene defects responsible for such severe phenotypes, we gain valuable insights into their function in human biology and their potential as drug targets. given that these targets are often involved in diseases beyond the rare genetic disorders in which they are first identified, we are developing proprietary product candidates to treat both orphan as well as more prevalent diseases.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 36.01 | 2026-10-27 | +6.46% | 0.833 |
| 1M | 38.02 | 2026-10-02 | +0.83% | 0.639 |
| 3M | 62.26 | 2026-08-03 | -38.43% | 0.731 |
| 6M | 57.40 | 2026-05-04 | -33.21% | 0.506 |
| 1Y | 41.12 | 2025-11-03 | -6.77% | 0.816 |
| 2Y | 41.71 | 2024-11-04 | -8.09% | — |
| 5Y | 34.10 | 2021-11-03 | +12.42% | 0.936 |
Xenon Pharmaceuticals Inc (NASDAQ:XENE) stock price today is $38.34, and today's volume is 1,246,675. XENE is up 1.901% today. The 30 day average volume is 1.83M. XENE market cap is $3.71B with 96.84M shares outstanding.